Vivani Medical (VANI) EBITDA (2014 - 2026)
Vivani Medical (VANI) posted quarterly EBITDA of -$6.8 million for Q1 2026, down 3.97% year-over-year from -$7.1 million in Q1 2025, and little changed quarter-over-quarter from -$6.8 million in Q4 2025.
Vivani Medical (VANI) EBITDA (2014 - 2026) Analysis & Trends
Vivani Medical's EBITDA history runs 13 years deep, the most recent figure standing at -$6.8 million for Q1 2026.
- In Q1 2026, EBITDA fell 3.97% year-over-year to -$6.8 million; the TTM figure through Mar 2026 stood at -$27.8 million (down 11.22% YoY), while the FY2025 annual figure was -$27.6 million, down 11.67% from the prior year.
- EBITDA for Q1 2026 stood at -$6.8 million, roughly flat from -$6.8 million in the prior quarter.
- The five-year high for EBITDA was -$3.9 million in Q1 2022, with the low at -$7.8 million in Q4 2022.
- The 5-year median for EBITDA is -$6.6 million (2025), against an average of -$6.3 million.
- The sharpest annual moves came in 2022 and 2023: EBITDA slumped 503.41% in 2022, then rose 20.19% in 2023.
- Vivani Medical's EBITDA stood at -$7.8 million in 2022, then climbed by 20.19% to -$6.2 million in 2023, then declined by 3.91% to -$6.5 million in 2024, then dropped by 5.42% to -$6.8 million in 2025, then dropped by 0.1% to -$6.8 million in 2026.
- Business Quant data shows VANI's EBITDA at -$6.8 million in Q1 2026, -$6.8 million in Q4 2025, and -$6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Vivani Medical | 122.36 Mn | 102.47 Mn | - | -6.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.87 Mn |
| Mar 31, 2026 | -6.82 Mn |
| Dec 31, 2025 | -6.81 Mn |
| Sep 30, 2025 | -6.73 Mn |
| Jun 30, 2025 | -7.46 Mn |
| Mar 31, 2025 | -6.56 Mn |
| Dec 31, 2024 | -6.46 Mn |
| Sep 30, 2024 | -6.31 Mn |
| Jun 30, 2024 | -5.68 Mn |
| Mar 31, 2024 | -6.23 Mn |
| Dec 31, 2023 | -6.22 Mn |
| Sep 30, 2023 | -7.14 Mn |
| Jun 30, 2023 | -7.00 Mn |
| Mar 31, 2023 | -6.60 Mn |
| Dec 31, 2022 | -7.79 Mn |
| Sep 30, 2022 | -5.44 Mn |
| Jun 30, 2022 | -4.09 Mn |
| Mar 31, 2022 | -3.91 Mn |
| Dec 31, 2021 | -1.29 Mn |
| Sep 30, 2021 | -3.49 Mn |